Chronic pelvic pain: Presumptive diagnosis and therapy using GnRH agonists

International Journal of Fertility and Women's Medicine

Volumn 44, Issue 3, 1999, Pages 131-138

  Lindheim, Steven R ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

(review article); Economics; Empirical treatment; Endometriosis; GnRH agonists; Lupron challenge; Medical treatment; Pelvic pain

Indexed keywords

DANAZOL; GONADORELIN AGONIST; LEUPRORELIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COPING BEHAVIOR; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DRUG EFFECT; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HUMAN; PELVIS PAIN SYNDROME; PREVALENCE; PRIORITY JOURNAL; WELLBEING;

ADOLESCENT; ADULT; CHRONIC DISEASE; COST OF ILLNESS; ENDOMETRIOSIS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; LAPAROSCOPY; LEUPROLIDE; PELVIC PAIN;

EID: 0032810602     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Walker EW, Sullivan MD, Stenchever MA: Use of antidepresssants in the management of women with chronic pelvic pain. Obstet Gynecol Clin North Am 20:743-752, 1993.
2. Mathias SD, Kupperman M, Liberman RF, et al: Chronic pelvic pain. Clin Obstet Gynecol 7:321-327, 1996.
3. Magni G, Caldieron C, Rigatti-Luchini S, et al: Chronic musculoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data. Pain 43:299-307, 1990.
4. Crook J, Rideout E, Browne G: The prevalence of pain complaints in a general population. Pain 18:299-314, 1984.
5. Reiter RC: A profile of women with chronic pelvic pain. Clin Obstet Gynecol 33:130-136, 1990.
6. Reiter RC, Gambone JC: Demographic and historical variables with idiopathic chronic pelvic pain. Obstet Gynecol 75:428-432, 1989.
7. Hulka JF, Peterson HB, Phillips JM, et al: Operative laparoscopy. American Association of Gynecologic Laparoscopists 1991 Membership Survey. J Reprod Med 38:569-571, 1993.
8. Dicker RC, Greenspan JR, Strauss LT, et al: Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 144:841-848, 1982.
9. Jamieson DJ, Steege JF: The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary practices. Obstet Gynecol 87: 55-58, 1996.
10. Mathias SD, Kuppermann M, Liberman RF, et al: Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 87:321-327, 1996.
11. Dmowski WP, Lesniewicz R, Rana N, et al: Changing trends in the diagnosis of endometriosis: a computer study of women with endometriosis presenting with chronic pelvic pain or infertility. Fertil Steril 67:238-243, 1997.
12. Interactive Discussion: Solving Clinical Problems. Current Management of Endometriosis. Hosp Pract September 1994 (special issue) 27-32.
13. Steege J: The evaluation and treatment of women with pelvic pain, in Sciarra J (ed): Gynecology and Obstetrics. Philadelphia, Harper & Row, pp 1-11, 1984.
14. Levy B: Pelvic pain: when is laparoscopy in order? OBG Management July 1996:52-54.
15. Malkasian GD, Podratz KC, Stanhope CR, et al: CA-125 in gynecologic practice. Am J Obstet Gynecol 155:515-518, 1986.
16. Cetin T, Ali Varder M, Demir C, et al: Etiology of serum CA-125 in patients with endometriosis treated with gonadotropin-releasing hormone agonist. Gynecol Obstet Invest 38:249-252, 1994.
17. Koninckx PR, Muyldermans M, Meulman C, et al: CA-125 in the management of endometriosis. Eur J Obstet Gynaecol Reprod Biol 49:109-113, 1993.
18. Koninckx PR, Ruttinen L, Seppal M, et al: CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis. Fertil Steril 57:523-530, 1992.
19. Zawin M, McCarthy S, Scoutt L, et al: Endometriosis: appearance and detection at MR imaging. Radiology 171:693-696, 1989.
20. Togashi K, Ozasa H, Konishi I: Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging. Radiology 171:531-534, 1989.
21. Koninckx PR, Lesaffre E, Meulman C, et al: Suggestive evidence that endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 55:759-75, 1991.
22. Carter JE: Hysteroscopic and laparoscopic findings in chronic pelvic pain. J Am Assoc Gynecol Laparosc Vol. 2, 1994.
23. Ripps BA, Martin DC: Focal pelvic tenderness, pelvic pain, dysmenorrhea, and endometriosis. J Reprod Med 26:470-472, 1991.
24. Howard FM: The role of laparoscopy in chronic pelvic pain: promises and pitfalls. Obstet Gynecol Surv 44(6):357-387, 1993.
25. DMowski WP: Endometriosis, in Glass RH (ed): Office Gynecology. Baltimore, Williams & Wilkins, pp 359-380, 1993.
26. Koninckx PR, Martin DC: Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa? Fertil Steril 58:924-928, 1992.
27. Martin DC: Depth of infiltration of endometriosis. J Gynecol Surg 5:55-60, 1989.
28. Murphy AA, Green WR, Bobbie D, et al: Unsuspected endometriosis documented by scanning electron microscopy in visually normal peritoneum. Fertil Steril 46:522-524, 1986.
29. Odom LD, et al: Immunocytochemical study of rats and myc proto-oncogene polypeptide expression in the human menstrual cycle. Am J Obstet Gynecol 161:1663-1668, 1989.
30. Haney AF, Muscato JJ, Weinberg JB: Peritoneal fluid cell populations in fertility patients. Fertil Steril 35:696-698, 1981.
31. Oosterlynck DJ, Meulman C, Waer M, et al: The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 58:290-295, 1992.
32. Gleicher N: Endometriosis: a new approach is needed. Hum Reprod 7:821-824, 1992.
33. Steel RW, Dmowski WP, Marmer DJ: Immunologic aspects of endometriosis. Am J Reprod Immunol 6:333-336, 1984.
34. Tamaya T, Motoyama T, Ohono Y, et al: Steroid receptor levels and histology of endometriosis and adenomyosis. Fertil Steril 31:396-400, 1979.
35. Olive DL, Schwartz LB: Endometriosis. N Engl J Med 328:1759-1769, 1993.
36. Dlugi Am, Miller JD, Knittle J, Lupron Study Group: Lupron depot in the treatment of endometriosis: a randomized placebo-controlled, double-blind study. Fertil Steril 54:419-427, 1990.
37. Buttram VC, Reiter RC, Ward S: Treatment of endometriosis with danazol: Report of a 6-year prospective study. Fertil Steril 43:353-360, 1985.
38. Waller KG, Shaw RW: Gonadotropin-releasing hormone analogs for the treatment of endometriosis: long-term follow-up. Fertil Steril 59:511-515, 1993.
39. Wright S, Valdes CT, Dunn RC, et al: Short-term Lupron or danazol therapy for pelvic endometriosis. Fertil Steril 63:504-507, 1995.
40. Braun DP, Gebel H, Rotman C: The development of cytotoxicity in peritoneal macrophages from women with endometriosis. Fertil Steril 57:1203-1210, 1992.
41. Surrey ES, Judd HL: Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrinol Metab 75:558-563, 1992.
42. Surrey ES, Fournet N, Voight B, et al: Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report. Obstet Gynecol 81:581-586, 1993.
43. Dickey RP, Taylor SN, Curole ND: Serum estradiol and donazol. I. Endometriosis response, side-effects, administration interval, concurrent spironolactone, and dexamethasone. Fertil Steril 42:709-716, 1984.
44. Data on file, TAP Holdings Inc.
45. Watkins WD, Peterson MB, Fletcher JR: Prostaglandings in Clinical Practice. New York, Raven Press, 1989.
46. Mishell DR, Jr, Kletzky OA, Brenner PF, et al: The effect of contraceptive steroids on hypothalamic-pituitary function. Am J Obstet Gynecol 128:60-74, 1977.
47. Mishell DR, Jr, Thorneycroft IH, Nakamura RM, et al: Serum estradiol in women ingesting combination oral contraceptive steroids. Am J Obstet Gynecol 114:923-928, 1972.
48. Friedman AJ, Lobel SM, Rein MS, et al: Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol 163:1114-1119, 1990.
49. Edgren RA, Sturtevant FM: Potencies of oral contraceptives. Am J Obstet Gynecol 125:1029-1038, 1976.
50. Edgren RA: Progestogens, in Givens JR (ed): Clinical Use of Sex Steroids. Chicago, Year Book, pp 1-29, 1980.
51. Mishell DR, Jr, Kharma KM, Thorneycroft IH: Estrogenic activity in women receiving an injectable progestogen for contraception. Am J Obstet Gynecol 113:372-377, 1972.
52. Song JY, Fraser IS: Effects of progestogens on human endometrium. Obstet Gynecol Surv 50:385-394, 1995.
53. Scanlan JM, Werner IJ, Legg RL, et al: Natural killer cell activity is reduced in association with oral contraceptive use. Psychonemoendocrinology 20:281-287, 1995.
54. Data on file, TAP Holdings Inc.
55. Barbieri RL: Treatment of endometriosis with GnRH agonists, in Barbieri RL, Friedman AJ (eds): Gonadotropin Releasing Hormone Analogs. Applications in Gynecology. New York, Elsevier, pp 63-76, 1991.
56. DeFazio J, Meldrum DR, Lu JKH: Acute ovarian responses to a long-acting agonist of gonadotropin-releasing hormone in ovulatory women and women with polycystic ovarian disease. Fertil Steril 44:453-458, 1985.
57. Carter JE, Trotter MM: GnRH analogs in the treatment of endometriosis. The Female Patient 20:13-20, 1995.